GlaxoSmithKline PLC
LSE:GSK
GlaxoSmithKline PLC
Selling, General & Administrative
GlaxoSmithKline PLC
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
GlaxoSmithKline PLC
LSE:GSK
|
Selling, General & Administrative
-£8.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
AstraZeneca PLC
LSE:AZN
|
Selling, General & Administrative
-$15B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-2%
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Selling, General & Administrative
-$50.4m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
Indivior PLC
LSE:INDV
|
Selling, General & Administrative
-$569m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Selling, General & Administrative
-$544m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-6%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Selling, General & Administrative
-£207m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-11%
|
See Also
What is GlaxoSmithKline PLC's Selling, General & Administrative?
Selling, General & Administrative
-8.9B
GBP
Based on the financial report for Mar 31, 2024, GlaxoSmithKline PLC's Selling, General & Administrative amounts to -8.9B GBP.
What is GlaxoSmithKline PLC's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-1%
Over the last year, the Selling, General & Administrative growth was -6%. The average annual Selling, General & Administrative growth rates for GlaxoSmithKline PLC have been 4% over the past three years , 1% over the past five years , and -1% over the past ten years .